ANCA vasculitis : from -omics to optics

Medicine & Life Sciences

1. Chronic Renal Insufficiency 100%
2. Vasculitis 99%
3. Cardiovascular Diseases 89%
4. Endothelin Receptors 73%
5. Proprotein Convertase 9 71%
6. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 70%
7. Phosphodiesterase 5 Inhibitors 62%
8. Systemic Vasculitis 62%
9. Troponin 57%
10. Vascular Stiffness 56%
11. Fibrinolysis 53%
12. Kidney Diseases 50%
13. Eye Diseases 50%
14. Endothelins 44%
15. Myocardial Infarction 44%
16. Kidney 43%
17. Therapeutic Uses 39%
18. Hypertension 36%
19. Endothelin A Receptors 33%
20. Optical Coherence Tomography 32%
21. Lipids 31%
22. Nifedipine 30%
23. Antibodies 26%
24. Placebos 26%
25. Pulse Wave Analysis 25%
26. Inflammation 21%
27. Blood Vessels 21%
28. Endothelin A Receptor Antagonists 20%
29. Retinal Vessels 18%
30. Vardenafil Dihydrochloride 18%
31. Therapeutics 17%
32. Tadalafil 17%
33. Endothelin-1 17%
34. Cross-Over Studies 16%
35. Diabetes Mellitus 16%
36. Sildenafil Citrate 15%
37. Biological Therapy 14%
38. Endothelium 14%
39. Molecular Imaging 14%
40. Pulmonary Arterial Hypertension 14%
41. Alkylating Agents 14%
42. Macrophage Activation 13%
43. Hydroxymethylglutaryl-CoA Reductase Inhibitors 13%
44. Peripheral Arterial Disease 13%
45. Monocytes 13%
46. Positron Emission Tomography Computed Tomography 13%
47. Wounds and Injuries 13%
48. Erectile Dysfunction 12%
49. Immune System Diseases 12%
50. Deep Learning 11%
51. Glucocorticoids 11%
52. Vasodilation 10%
53. Cholesterol 10%
54. Pharmaceutical Preparations 10%
55. Eye 10%
56. Psychological Inhibition 9%
57. Case-Control Studies 8%
58. Microcirculation 8%
59. Lipoprotein(a) 8%
60. Blood Platelets 8%
61. Stroke 8%
62. Pharmacology 8%
63. Magnetic Resonance Imaging 8%
64. Capillaries 7%
65. Endothelin B Receptors 7%
66. Cytokines 7%
67. Healthy Volunteers 7%
68. Acute Coronary Syndrome 6%
69. Dyslipidemias 6%
70. Proteinuria 6%
71. Health 6%
72. Angiography 6%
73. Plethysmography 6%
74. Cause of Death 6%
75. Platelet Activation 5%
76. Tissue Plasminogen Activator 5%
77. Triglycerides 5%
78. Risk Reduction Behavior 5%
79. Forearm 5%
80. Pathology 5%